RSS   Newsletter   Contact   Advertise with us
Post Online Media

Achaogen appoints Tobin Schilke as CFO

AchaogenAchaogen, a clinical-stage biopharmaceutical company, announced the addition of Tobin Schilke as chief financial officer from July 5, 2016.
Article continues below

READ MORE Achaogen appoints Karen Bernstein to board

Mr. Schilke is joining Achaogen after 13 years at Roche/Genentech where he has been, most recently, the CFO and Company Director of Roche Products Limited in the United Kingdom.

Previously, Mr. Schilke had overall FP&A responsibility for Genentech's Commercial BioOncology business and, prior to Genentech, led a number of successful acquisition and spin-out deals as a member of the Roche Corporate M&A team.

Mr. Schilke received a Bachelor of Science degree in Chemical Engineering from Lafayette College in Easton, Pennsylvania, a Masters of Science degree from University of California in Berkeley, California, and a Masters of Business Administration degree from Cornell University’s Johnson Graduate School of Management in Ithaca, New York.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy